Abstract
In vitro studies of muscle mitochondrial metabolism in patients with mitochondrial myopathy have identified a variety of functional defects of the mitochondrial respiratory chain, predominantly affecting complex I (NADH-CoQ reductase) or complex III (ubiquinol–cytochrome c reductase) in adult cases1–3. These two enzymes consist of ∼36 subunits, eight of which are encoded by mitochondrial DNA (mtDNA)4–6. The increased incidence of maternal, as opposed to paternal, transmission in familial mitochondrial myopathy suggests that these disorders may be caused by mutations of mtDNA7,8. Multiple restriction endonuclease analysis of leukocyte mtDNA from patients with the disease, and their relatives, showed no differences in cleavage patterns between affected and unaffected individuals in any single maternal line. When muscle mtDNA was studied, nine of 25 patients were found to have two populations of muscle mtDNA, one of which had deletions of up to 7 kilobases in length. These observations demonstrate that mtDNA heteroplasmy can occur in man and that human disease may be associated with defects of the mitochondrial genome.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Morgan-Hughes, J. A. et al. Brain 100, 617–640 (1977).
Morgan-Hughes, J. A., Hayes, D. J., Cooper, M. & Clark, J. B. Biochem. Soc. Trans. 13, 648–650 (1985).
Petty, R. K. H., Harding, A. E. & Morgan-Hughes, J. A. Brain 109, 915–938 (1986).
Hatefi, Y. A. Rev. Biochem. 54, 1015–69 (1985).
Chomyn, A. et al. Nature 314, 592–597 (1985).
Chomyn, A. et al. in Achievements and Perspectives of Mitochondrial Research Vol. II: Biogenesis (eds Quagliariello, E. et al.) 259–275 (Elsevier, Amsterdam, 1985).
Hudgson, P., Bradley, W. G. & Jenkison, M. J. neurol. Sci. 16, 343–370 (1972).
Egger, J. & Wilson, J. N. Eng. J. Med. 309, 142–145 (1983).
DiMauro, S., Bonilla, E., Zeviani, M., Nakagawa, M. & DeVivo, D. C. Ann. Neurol. 17, 521–538 (1985).
Harding, A. E., Petty, R. K. H. & Morgan-Hughes, J. A. Muscle Nerve Suppl. 5, 179 (1986).
Harding, A. E., Holt, I. J. & Morgan-Hughes, J. A. J. med. Genet. 4, 243(1987).
Anderson, S. et al. Nature 290, 457–465 (1981).
Monnat, R. J. & Loeb, L. A. Proc. natn. Acad. Sci. U.S.A. 82, 2895–2899 (1985).
Cann, R. L., Stoneking, M. & Wilson, A. C. Nature 325, 31–36 (1987).
Hauswirth, W. W. & Laipis, P. J. Proc. natn. Acad. Sci. U.S.A. 79, 4686–4690 (1982).
Hauswirth, W. W., van de Walle, M. J., Laipis, P. J. & Olivo, P. D. Cell 37, 1001–1007 (1984).
Boursot, P., Yonekawa, H. & Bonhomme, F. Molec. Biol. Evol. 4, 46–55 (1987).
Birky, C. W. Ann. Rev. Genet. 12, 471–512 (1978).
Stickland, N. C. J. Anat. 132, 557–579 (1981).
Hayes, D. J. et al. J. neurol. Sci. 71, 105–118 (1985).
Feinberg, A. P. & Vogelstein, B. Anal. Biochem. 132, 6–13 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holt, I., Harding, A. & Morgan-Hughes, J. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331, 717–719 (1988). https://doi.org/10.1038/331717a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/331717a0
- Springer Nature Limited
This article is cited by
-
Interleukin-6-elicited chronic neuroinflammation may decrease survival but is not sufficient to drive disease progression in a mouse model of Leigh syndrome
Journal of Inflammation (2024)
-
MmisAT and MmisP: an efficient and accurate suite of variant analysis toolkit for primary mitochondrial diseases
Human Genomics (2023)
-
Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and cancer-specific mortality
Nature Communications (2023)
-
Site-specific CRISPR-based mitochondrial DNA manipulation is limited by gRNA import
Scientific Reports (2022)
-
Gene therapy for primary mitochondrial diseases: experimental advances and clinical challenges
Nature Reviews Neurology (2022)